<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38463416</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>12</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2689-288X</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>1</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Neurotrauma reports</Title><ISOAbbreviation>Neurotrauma Rep</ISOAbbreviation></Journal><ArticleTitle>Traumatic Brain Injury in the Long-COVID Era.</ArticleTitle><Pagination><StartPage>81</StartPage><EndPage>94</EndPage><MedlinePgn>81-94</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/neur.2023.0067</ELocationID><Abstract><AbstractText>Major determinants of the biological background or reserve, such as age, biological sex, comorbidities (diabetes, hypertension, obesity, etc.), and medications (e.g., anticoagulants), are known to affect outcome after traumatic brain injury (TBI). With the unparalleled data richness of coronavirus disease 2019 (COVID-19; &#x223c;375,000 and counting!) as well as the chronic form, long-COVID, also called post-acute sequelae SARS-CoV-2 infection (PASC), publications (&#x223c;30,000 and counting) covering virtually every aspect of the diseases, pathomechanisms, biomarkers, disease phases, symptomatology, etc., have provided a unique opportunity to better understand and appreciate the holistic nature of diseases, interconnectivity between organ systems, and importance of biological background in modifying disease trajectories and affecting outcomes. Such a holistic approach is badly needed to better understand TBI-induced conditions in their totality. Here, I briefly review what is known about long-COVID/PASC, its underlying-suspected-pathologies, the pathobiological changes induced by TBI, in other words, the TBI endophenotypes, discuss the intersection of long-COVID/PASC and TBI-induced pathobiologies, and how by considering some of the known factors affecting the person's biological background and the inclusion of mechanistic molecular biomarkers can help to improve the clinical management of TBI patients.</AbstractText><CopyrightInformation>&#xa9; Denes V. Agoston 2023; Published by Mary Ann Liebert, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Agoston</LastName><ForeName>Denes V</ForeName><Initials>DV</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Physiology, and Genetics, School of Medicine, Uniformed Services University, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurotrauma Rep</MedlineTA><NlmUniqueID>101773091</NlmUniqueID><ISSNLinking>2689-288X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">biological reserve</Keyword><Keyword MajorTopicYN="N">comorbidities</Keyword><Keyword MajorTopicYN="N">traumatic brain injury</Keyword></KeywordList><CoiStatement>No competing financial interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>11</Day><Hour>4</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38463416</ArticleId><ArticleId IdType="pmc">PMC10923549</ArticleId><ArticleId IdType="doi">10.1089/neur.2023.0067</ArticleId><ArticleId IdType="pii">10.1089/neur.2023.0067</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Karr JE, Iverson GL, Berghem K, et al. . Complicated mild traumatic brain injury in older adults: post-concussion symptoms and functional outcome at one week post injury. Brain Inj 2020;34(1):26&#x2013;33; doi: 10.1080/02699052.2019.1669825</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02699052.2019.1669825</ArticleId><ArticleId IdType="pubmed">31550173</ArticleId></ArticleIdList></Reference><Reference><Citation>Levin SG, Pershina EV, Bugaev-Makarovskiy NA, et al. . Why do levels of anti-inflammatory cytokines increase during memory acquisition? Neuroscience 2021;473:159&#x2013;169; doi: 10.1016/j.neuroscience.2021.08.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2021.08.007</ArticleId><ArticleId IdType="pubmed">34418518</ArticleId></ArticleIdList></Reference><Reference><Citation>dell'Aquila M, Maiese A, De Matteis A, et al. . Traumatic brain injury: estimate of the age of the injury based on neuroinflammation, endothelial activation markers and adhesion molecules. Histol Histopathol 2021;36(8):795&#x2013;806; doi: 10.14670/hh-18-319</Citation><ArticleIdList><ArticleId IdType="doi">10.14670/hh-18-319</ArticleId><ArticleId IdType="pubmed">33625724</ArticleId></ArticleIdList></Reference><Reference><Citation>Delage C, Taib T, Mamma C, et al. . Traumatic brain injury: an age-dependent view of post-traumatic neuroinflammation and its treatment. Pharmaceutics 2021;13(10):1624; doi: 10.3390/pharmaceutics13101624</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics13101624</ArticleId><ArticleId IdType="pmc">PMC8537402</ArticleId><ArticleId IdType="pubmed">34683918</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim T, Chelluboina B, Chokkalla AK, et al. . Age and sex differences in the pathophysiology of acute CNS injury. Neurochem Int 2019;127:22&#x2013;28; doi: 10.1016/j.neuint.2019.01.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2019.01.012</ArticleId><ArticleId IdType="pmc">PMC6579702</ArticleId><ArticleId IdType="pubmed">30654116</ArticleId></ArticleIdList></Reference><Reference><Citation>Biegon A. Considering biological sex in traumatic brain injury. Front Neurol 2021;12:576366; doi: 10.3389/fneur.2021.576366</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.576366</ArticleId><ArticleId IdType="pmc">PMC7902907</ArticleId><ArticleId IdType="pubmed">33643182</ArticleId></ArticleIdList></Reference><Reference><Citation>Krukowski K. Short review: The impact of sex on neuroimmune and cognitive outcomes after traumatic brain injury. Brain Behav Immun Health 2021;16:100327; doi: 10.1016/j.bbih.2021.100327</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2021.100327</ArticleId><ArticleId IdType="pmc">PMC8474220</ArticleId><ArticleId IdType="pubmed">34589813</ArticleId></ArticleIdList></Reference><Reference><Citation>Levin HS, Temkin NR, Barber J, et al. . Association of sex and age with mild traumatic brain injury-related symptoms: a TRACK-TBI study. JAMA Netw Open 2021;4(4):e213046; doi: 10.1001/jamanetworkopen.2021.3046</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.3046</ArticleId><ArticleId IdType="pmc">PMC8025125</ArticleId><ArticleId IdType="pubmed">33822070</ArticleId></ArticleIdList></Reference><Reference><Citation>Saunders LL, Selassie AW, Hill EG, et al. . Pre-existing health conditions and repeat traumatic brain injury. Arch Phys Med Rehabil 2009;90(11):1853&#x2013;1859; doi: 10.1016/j.apmr.2009.05.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2009.05.020</ArticleId><ArticleId IdType="pubmed">19887208</ArticleId></ArticleIdList></Reference><Reference><Citation>Dell KC, Grossner EC, Staph J, et al. . A population-based study of pre-existing health conditions in traumatic brain injury. Neurotrauma Rep 2021;2(1):255&#x2013;269; doi: 10.1089/neur.2020.0065</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neur.2020.0065</ArticleId><ArticleId IdType="pmc">PMC8244518</ArticleId><ArticleId IdType="pubmed">34223556</ArticleId></ArticleIdList></Reference><Reference><Citation>Spano PJ, 2nd, Shaikh S, Boneva D, et al. . Anticoagulant chemoprophylaxis in patients with traumatic brain injuries: a systematic review. J Trauma Acute Care Surg 2020;88(3):454&#x2013;460; doi: 10.1097/ta.0000000000002580</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ta.0000000000002580</ArticleId><ArticleId IdType="pubmed">31923051</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiegele M, Sch&#xf6;chl H, Haushofer A, et al. . Diagnostic and therapeutic approach in adult patients with traumatic brain injury receiving oral anticoagulant therapy: an Austrian interdisciplinary consensus statement. Crit Care 2019;23(1):62; doi: 10.1186/s13054-019-2352-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2352-6</ArticleId><ArticleId IdType="pmc">PMC6387521</ArticleId><ArticleId IdType="pubmed">30795779</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg M, Maralakunte M, Garg S, et al. . The conundrum of &#x2018;long-COVID-19&#x2019;: a narrative review. Int J Gen Med 2021;14:2491&#x2013;2506; doi: 10.2147/ijgm.S316708</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/ijgm.S316708</ArticleId><ArticleId IdType="pmc">PMC8214209</ArticleId><ArticleId IdType="pubmed">34163217</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hakeim HK, Al-Rubaye HT, Al-Hadrawi DS, et al. . Long-COVID post-viral chronic fatigue and affective symptoms are associated with oxidative damage, lowered antioxidant defenses and inflammation: a proof of concept and mechanism study. Mol Psychiatry 2023;28(2):564&#x2013;578; doi: 10.1038/s41380-022-01836-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01836-9</ArticleId><ArticleId IdType="pmc">PMC9589528</ArticleId><ArticleId IdType="pubmed">36280755</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol 2021;12:698169; doi: 10.3389/fmicb.2021.698169</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, et al. . Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 2023;21(3):133&#x2013;146; doi: 10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Pye A, Roberts SR, Blennerhassett A, et al. . A public health approach to estimating the need for long COVID services. J Public Health (Oxf) 2023;45(1):169&#x2013;175; doi: 10.1093/pubmed/fdab365</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pubmed/fdab365</ArticleId><ArticleId IdType="pubmed">34651183</ArticleId></ArticleIdList></Reference><Reference><Citation>Nittas V, Gao M, West EA, et al. . Long COVID through a public health lens: an umbrella review. Public Health Rev 2022;43:1604501; doi: 10.3389/phrs.2022.1604501</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/phrs.2022.1604501</ArticleId><ArticleId IdType="pmc">PMC8963488</ArticleId><ArticleId IdType="pubmed">35359614</ArticleId></ArticleIdList></Reference><Reference><Citation>Facing up to long COVID. Lancet 2020;396(10266):1861; doi: 10.1016/s0140-6736(20)32662-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(20)32662-3</ArticleId><ArticleId IdType="pmc">PMC7834723</ArticleId><ArticleId IdType="pubmed">33308453</ArticleId></ArticleIdList></Reference><Reference><Citation>Merkler AE, Parikh NS, Mir S, et al. . Risk of ischemic stroke in patients with coronavirus disease 2019 (COVID-19) vs patients with influenza. JAMA Neurol 2020;77(11):1&#x2013;7; doi: 10.1001/jamaneurol.2020.2730</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.2730</ArticleId><ArticleId IdType="pmc">PMC7333175</ArticleId><ArticleId IdType="pubmed">32614385</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein M. Traumatic brain injury: a silent epidemic. Ann Neurol 1990;27(3):327; doi: 10.1002/ana.410270315</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410270315</ArticleId><ArticleId IdType="pubmed">2327740</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascrell B Jr. Traumatic brain injury: the silent epidemic. N J Med 2001;98(11):47&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">11771339</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanafy S, Amodio V, Haag HL, et al. . Is it prime time for sex and gender considerations in traumatic brain injury? Perspectives of rehabilitation care professionals. Disabil Rehabil 2022;44(5):684&#x2013;692; doi: 10.1080/09638288.2020.1774670</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09638288.2020.1774670</ArticleId><ArticleId IdType="pubmed">32574090</ArticleId></ArticleIdList></Reference><Reference><Citation>Mollayeva T, Bordignon C, Ishtiaq M, et al. . Knowledge of sex and gender and related information needs in patients with traumatic brain injury: in-depth interview study. Disabil Rehabil 2021;43(13):1872&#x2013;1882; doi: 10.1080/09638288.2019.1683235</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09638288.2019.1683235</ArticleId><ArticleId IdType="pubmed">31702962</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanafy S, Xiong C, Chan V, et al. . Comorbidity in traumatic brain injury and functional outcomes: a systematic review. Eur J Phys Rehabil Med 2021;57(4):535&#x2013;550; doi: 10.23736/s1973-9087.21.06491-1</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/s1973-9087.21.06491-1</ArticleId><ArticleId IdType="pmc">PMC10396401</ArticleId><ArticleId IdType="pubmed">33541041</ArticleId></ArticleIdList></Reference><Reference><Citation>Maas AIR, Menon DK, Manley GT, et al. . Traumatic brain injury: progress and challenges in prevention, clinical care, and research. Lancet Neurol 2022;21(11):1004&#x2013;1060; doi: 10.1016/s1474-4422(22)00309-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(22)00309-x</ArticleId><ArticleId IdType="pmc">PMC10427240</ArticleId><ArticleId IdType="pubmed">36183712</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajalu BM, Indira Devi B, Shukla DP, et al. . Traumatic brain injury during COVID-19 pandemic-time-series analysis of a natural experiment. BMJ Open 2022;12(4):e052639; doi: 10.1136/bmjopen-2021-052639</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-052639</ArticleId><ArticleId IdType="pmc">PMC8995573</ArticleId><ArticleId IdType="pubmed">35396279</ArticleId></ArticleIdList></Reference><Reference><Citation>Damara FA, Muchamad GR, Anton A, et al. . Epidemiological pattern of traumatic brain injury in the COVID-19 pandemic: a systematic review and meta-analysis. World Neurosurg 2022;161:e698&#x2013;e709; doi: 10.1016/j.wneu.2022.02.081</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2022.02.081</ArticleId><ArticleId IdType="pmc">PMC8881220</ArticleId><ArticleId IdType="pubmed">35227924</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathian B, Asim M, Banerjee I, et al. . Impact of COVID-19 on clinical trials and clinical research: a systematic review. Nepal J Epidemiol 2020;10(3):878&#x2013;887; doi: 10.3126/nje.v10i3.31622</Citation><ArticleIdList><ArticleId IdType="doi">10.3126/nje.v10i3.31622</ArticleId><ArticleId IdType="pmc">PMC7538012</ArticleId><ArticleId IdType="pubmed">33042591</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller P, Williams A.. COVID-19's Impact on Clinical Research. In: RTI Press Research Brief. RTI Press: Research Triangle Park, NC; 2014.</Citation><ArticleIdList><ArticleId IdType="pubmed">37289930</ArticleId></ArticleIdList></Reference><Reference><Citation>Teng H, Wang Z, Yang X, et al. . The impact of COVID-19 on clinical outcomes in people undergoing neurosurgery: a systematic review and meta-analysis. Syst Rev 2023;12(1):137; doi: 10.1186/s13643-023-02291-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-023-02291-5</ArticleId><ArticleId IdType="pmc">PMC10405503</ArticleId><ArticleId IdType="pubmed">37550713</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dorn A. COVID-19 and readjusting clinical trials. Lancet 2020;396(10250):523&#x2013;524; doi: 10.1016/s0140-6736(20)31787-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(20)31787-6</ArticleId><ArticleId IdType="pmc">PMC7440868</ArticleId><ArticleId IdType="pubmed">32828180</ArticleId></ArticleIdList></Reference><Reference><Citation>Lester A, Leach P, Zaben M. The impact of the COVID-19 pandemic on traumatic brain injury management: lessons learned over the first year. World Neurosurg 2021;156:28&#x2013;32; doi: 10.1016/j.wneu.2021.09.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2021.09.030</ArticleId><ArticleId IdType="pmc">PMC8435471</ArticleId><ArticleId IdType="pubmed">34530146</ArticleId></ArticleIdList></Reference><Reference><Citation>Agoston DV. COVID-19 and traumatic brain injury (TBI); what we can learn from the viral pandemic to better understand the biology of TBI, improve diagnostics and develop evidence-based treatments. Front Neurol 2021;12:752937; doi: 10.3389/fneur.2021.752937</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.752937</ArticleId><ArticleId IdType="pmc">PMC8720751</ArticleId><ArticleId IdType="pubmed">34987462</ArticleId></ArticleIdList></Reference><Reference><Citation>Agoston DV. Big Data, Artificial Intelligence and Machine Learning in Neurotrauma. In: Leveraging Biomedical and Healthcare Data: Semantics, Analytics and Knowledge. (Kobeissy F, Alawieh A, Zaraket FA, Wang K. ed.) Academic Press: London; 2019; pp. 53&#x2013;75.</Citation></Reference><Reference><Citation>Perlis RH, Santillana M, Ognyanova K, et al. . Prevalence and correlates of long COVID symptoms among US adults. JAMA Netw Open 2022;5(10):e2238804; doi: 10.1001/jamanetworkopen.2022.38804</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.38804</ArticleId><ArticleId IdType="pmc">PMC9614581</ArticleId><ArticleId IdType="pubmed">36301542</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, et al. . Global prevalence of post COVID-19 condition or long COVID: a meta-analysis and systematic review. J Infect Dis 2022;226(9):1593&#x2013;1607; doi: 10.1093/infdis/jiac136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Ayuzo Del Valle NC, et al. . Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci Rep 2022;12(1):9950; doi: 10.1038/s41598-022-13495-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-13495-5</ArticleId><ArticleId IdType="pmc">PMC9226045</ArticleId><ArticleId IdType="pubmed">35739136</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugiyama A, Miwata K, Kitahara Y, et al. . Long COVID occurrence in COVID-19 survivors. Sci Rep 2022;12(1):6039; doi: 10.1038/s41598-022-10051-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-10051-z</ArticleId><ArticleId IdType="pmc">PMC8996498</ArticleId><ArticleId IdType="pubmed">35411017</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. . Post-acute COVID-19 syndrome. Nat Med 2021;27(4):601&#x2013;615; doi: 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisnivesky JP, Govindarajulu U, Bagiella E, et al. . Association of vaccination with the persistence of post-COVID symptoms. J Gen Intern Med 2022;37(7):1748&#x2013;1753; doi: 10.1007/s11606-022-07465-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07465-w</ArticleId><ArticleId IdType="pmc">PMC8906626</ArticleId><ArticleId IdType="pubmed">35266128</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherlinger M, Pijnenburg L, Chatelus E, et al. . Effect of SARS-CoV-2 vaccination on symptoms from post-acute sequelae of COVID-19: results from the nationwide VAXILONG Study. Vaccines (Basel) 2021;10(1):46; doi: 10.3390/vaccines10010046</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10010046</ArticleId><ArticleId IdType="pmc">PMC8781023</ArticleId><ArticleId IdType="pubmed">35062706</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynberg E, Han AX, Boyd A, et al. . The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): a prospective cohort study. Vaccine 2022;40(32):4424&#x2013;4431; doi: 10.1016/j.vaccine.2022.05.090</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.05.090</ArticleId><ArticleId IdType="pmc">PMC9170535</ArticleId><ArticleId IdType="pubmed">35725782</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, et al. . Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 2022;185(5):881&#x2013;895.e20; doi: 10.1016/j.cell.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, et al. . Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med 2021;18(9):e1003773; doi: 10.1371/journal.pmed.1003773</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishnan RK, Kashour T, Hamid Q, et al. . Unraveling the mystery surrounding post-acute sequelae of COVID-19. Front Immunol 2021;12:686029; doi: 10.3389/fimmu.2021.686029</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.686029</ArticleId><ArticleId IdType="pmc">PMC8278217</ArticleId><ArticleId IdType="pubmed">34276671</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedberg P, Granath F, Bruchfeld J, et al. . Post COVID-19 condition diagnosis: a population-based cohort study of occurrence, associated factors, and healthcare use by severity of acute infection. J Intern Med 2023. Feb;293(2):246&#x2013;258; doi: 10.1111/joim.13584</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13584</ArticleId><ArticleId IdType="pmc">PMC9877994</ArticleId><ArticleId IdType="pubmed">36478477</ArticleId></ArticleIdList></Reference><Reference><Citation>Sylvester SV, Rusu R, Chan B, et al. . Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: a review. Curr Med Res Opin 2022;38(8):1391&#x2013;1399; doi: 10.1080/03007995.2022.2081454</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03007995.2022.2081454</ArticleId><ArticleId IdType="pubmed">35726132</ArticleId></ArticleIdList></Reference><Reference><Citation>Pel&#xe0; G, Goldoni M, Solinas E, et al. . Sex-related differences in long-COVID-19 syndrome. J Womens Health (Larchmt) 2022;31(5):620&#x2013;630; doi: 10.1089/jwh.2021.0411</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jwh.2021.0411</ArticleId><ArticleId IdType="pubmed">35333613</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Mart&#xed;n-Guerrero JD, Pellicer-Valero &#xd3;J, et al. Female sex is a risk factor associated with long-term post-COVID related-symptoms but not with COVID-19 Symptoms: the LONG-COVID-EXP-CM Multicenter Study. J Clin Med 2022;11(2):413; doi: 10.3390/jcm11020413</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11020413</ArticleId><ArticleId IdType="pmc">PMC8778106</ArticleId><ArticleId IdType="pubmed">35054108</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanou MI, Palaiodimou L, Bakola E, et al. . Neurological manifestations of long-COVID syndrome: a narrative review. Ther Adv Chronic Dis 2022;13:20406223221076890; doi: 10.1177/20406223221076890</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20406223221076890</ArticleId><ArticleId IdType="pmc">PMC8859684</ArticleId><ArticleId IdType="pubmed">35198136</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol 2022;23(2):194&#x2013;202; doi: 10.1038/s41590-021-01104-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi OL, Hughes SE, Turner G, et al. . Symptoms, complications and management of long COVID: a review. J R Soc Med 2021;114(9):428&#x2013;442; doi: 10.1177/01410768211032850</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hakeim HK, Al-Rubaye HT, Almulla AF, et al. . Chronic fatigue, depression and anxiety symptoms in long COVID are strongly predicted by neuroimmune and neuro-oxidative pathways which are caused by the inflammation during acute infection. J Clin Med 2023;12(2):511; doi: 10.3390/jcm12020511</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12020511</ArticleId><ArticleId IdType="pmc">PMC9865328</ArticleId><ArticleId IdType="pubmed">36675440</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha C, Baek G. Symptoms and management of long COVID: a scoping review. J Clin Nurs 2021; doi: 10.1111/jocn.16150</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocn.16150</ArticleId><ArticleId IdType="pubmed">34913540</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes LD, Ingram J, Sculthorpe NF. More than 100 persistent symptoms of SARS-CoV-2 (Long COVID): a scoping review. Front Med (Lausanne) 2021;8:750378; doi: 10.3389/fmed.2021.750378</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.750378</ArticleId><ArticleId IdType="pmc">PMC8591053</ArticleId><ArticleId IdType="pubmed">34790680</ArticleId></ArticleIdList></Reference><Reference><Citation>Healey Q, Sheikh A, Daines L, et al. . Symptoms and signs of long COVID: a rapid review and meta-analysis. J Glob Health 2022;12:05014; doi: 10.7189/jogh.12.05014</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.12.05014</ArticleId><ArticleId IdType="pmc">PMC9125197</ArticleId><ArticleId IdType="pubmed">35596571</ArticleId></ArticleIdList></Reference><Reference><Citation>Espay AJ, Aybek S, Carson A, et al. . Current concepts in diagnosis and treatment of functional neurological disorders. JAMA Neurol 2018;75(9):1132&#x2013;1141; doi: 10.1001/jamaneurol.2018.1264</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2018.1264</ArticleId><ArticleId IdType="pmc">PMC7293766</ArticleId><ArticleId IdType="pubmed">29868890</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Sullivan O. Long-term sequelae following previous coronavirus epidemics. Clin Med (Lond) 2021;21(1):e68&#x2013;e70; doi: 10.7861/clinmed.2020-0204</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0204</ArticleId><ArticleId IdType="pmc">PMC7850177</ArticleId><ArticleId IdType="pubmed">33144403</ArticleId></ArticleIdList></Reference><Reference><Citation>Malkova AM, Shoenfeld Y. Autoimmune autonomic nervous system imbalance and conditions: chronic fatigue syndrome, fibromyalgia, silicone breast implants, COVID and post-COVID syndrome, sick building syndrome, post-orthostatic tachycardia syndrome, autoimmune diseases and autoimmune/inflammatory syndrome induced by adjuvants. Autoimmun Rev 2023;22(1):103230; doi: 10.1016/j.autrev.2022.103231</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2022.103231</ArticleId><ArticleId IdType="pubmed">36347462</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen J, Whiteside LK, Bulger EM, et al. . Post-traumatic stress disorder (PTSD) symptoms and alcohol and drug use comorbidity at 25 US level I trauma centers. Trauma Surg Acute Care Open 2022;7(1):e000913; doi: 10.1136/tsaco-2022-000913</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/tsaco-2022-000913</ArticleId><ArticleId IdType="pmc">PMC9358953</ArticleId><ArticleId IdType="pubmed">35979039</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith DH, Johnson VE, Stewart W. Chronic neuropathologies of single and repetitive TBI: substrates of dementia? Nat Rev Neurol 2013;9(4):211&#x2013;221; doi: 10.1038/nrneurol.2013.29</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.29</ArticleId><ArticleId IdType="pmc">PMC4513655</ArticleId><ArticleId IdType="pubmed">23458973</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso-Canovas A, Kurtis MM, Gomez-Mayordomo V, et al. . Functional neurological disorders after COVID-19 and SARS-CoV-2 vaccines: a national multicentre observational study. J Neurol Neurosurg Psychiatry 2023;94(9):776&#x2013;777; doi: 10.1136/jnnp-2022-330885</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2022-330885</ArticleId><ArticleId IdType="pubmed">36889911</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrott B, Head R, Pringle KG, et al. . &#x201c;LONG COVID&#x201d;&#x2014;a hypothesis for understanding the biological basis and pharmacological treatment strategy. Pharmacol Res Perspect 2022;10(1):e00911; doi: 10.1002/prp2.911</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prp2.911</ArticleId><ArticleId IdType="pmc">PMC8929332</ArticleId><ArticleId IdType="pubmed">35029046</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani A, Morrone MC, Patrono C, et al. . Long Covid: where we stand and challenges ahead. Cell Death Differ 2022;29(10):1891&#x2013;1900; doi: 10.1038/s41418-022-01052-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-022-01052-6</ArticleId><ArticleId IdType="pmc">PMC9449925</ArticleId><ArticleId IdType="pubmed">36071155</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond) 2021;53(10):737&#x2013;754; doi: 10.1080/23744235.2021.1924397</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer L, Laksono BM, de Vrij FMS, et al. . The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2. Trends Neurosci 2022;45(5):358&#x2013;368; doi: 10.1016/j.tins.2022.02.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2022.02.006</ArticleId><ArticleId IdType="pmc">PMC8890977</ArticleId><ArticleId IdType="pubmed">35279295</ArticleId></ArticleIdList></Reference><Reference><Citation>McQuaid C, Brady M, Deane R. SARS-CoV-2: is there neuroinvasion? Fluids Barriers CNS 2021;18(1):32; doi: 10.1186/s12987-021-00267-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12987-021-00267-y</ArticleId><ArticleId IdType="pmc">PMC8278192</ArticleId><ArticleId IdType="pubmed">34261487</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B, Julg B, Mohandas S, et al. ; RECOVER Mechanistic Pathways Task Force. Viral persistence, reactivation, and mechanisms of long COVID. Elife 2023;12:e86015; doi: 10.7554/eLife.86015</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86015</ArticleId><ArticleId IdType="pmc">PMC10159620</ArticleId><ArticleId IdType="pubmed">37140960</ArticleId></ArticleIdList></Reference><Reference><Citation>Torices S, Motta C, da Rosa B, et al. . SARS-CoV-2 infection of human brain microvascular endothelial cells leads to inflammatory activation through NF-&#x3ba;B non-canonical pathway and mitochondrial remodeling. Res Sq 2022; doi: 10.21203/rs.3.rs-1762855/v1</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1762855/v1</ArticleId><ArticleId IdType="pmc">PMC10056985</ArticleId><ArticleId IdType="pubmed">36992454</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkai I, Mayer MG, Hellmers LM, et al. . Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates. Nat Commun 2022;13(1):1745; doi: 10.1038/s41467-022-29440-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29440-z</ArticleId><ArticleId IdType="pmc">PMC8975902</ArticleId><ArticleId IdType="pubmed">35365631</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Berger NA, Davis PB, et al. . COVID-19 rebound after Paxlovid and Molnupiravir during January-June 2022. medRxiv 2022; doi: 10.1101/2022.06.21.22276724</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.06.21.22276724</ArticleId></ArticleIdList></Reference><Reference><Citation>Viszlayov&#xe1; D, Sojka M, Dobrodenkov&#xe1; S, et al. . SARS-CoV-2 RNA in the cerebrospinal fluid of a patient with long COVID. Ther Adv Infect Dis 2021;8:20499361211048572; doi: 10.1177/20499361211048572</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20499361211048572</ArticleId><ArticleId IdType="pmc">PMC8511908</ArticleId><ArticleId IdType="pubmed">34659752</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweitzer F, Goereci Y, Franke C, et al. . Cerebrospinal fluid analysis post-COVID-19 is not suggestive of persistent central nervous system infection. Ann Neurol 2022;91(1):150&#x2013;157; doi: 10.1002/ana.26262</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26262</ArticleId><ArticleId IdType="pmc">PMC8653324</ArticleId><ArticleId IdType="pubmed">34724243</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu SW, Ilyas I, Weng JP. Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies. Acta Pharmacol Sin 2023;44(4):695&#x2013;709; doi: 10.1038/s41401-022-00998-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-022-00998-0</ArticleId><ArticleId IdType="pmc">PMC9574180</ArticleId><ArticleId IdType="pubmed">36253560</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosino P, Calcaterra IL, Mosella M, et al. . Endothelial dysfunction in COVID-19: a unifying mechanism and a potential therapeutic target. Biomedicines 2022;10(4):812; doi: 10.3390/biomedicines10040812</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10040812</ArticleId><ArticleId IdType="pmc">PMC9029464</ArticleId><ArticleId IdType="pubmed">35453563</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd8;stergaard L. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol Rep 2021;9(3):e14726; doi: 10.14814/phy2.14726</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.14726</ArticleId><ArticleId IdType="pmc">PMC7849453</ArticleId><ArticleId IdType="pubmed">33523608</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanini G, Selleri V, Roncati L, et al. . Vascular &#x201c;long COVID&#x201d;: a new vessel disease? Angiology 2024;75(1):8&#x2013;14; doi: 10.1177/00033197231153204</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00033197231153204</ArticleId><ArticleId IdType="pmc">PMC9895315</ArticleId><ArticleId IdType="pubmed">36652923</ArticleId></ArticleIdList></Reference><Reference><Citation>Acanfora D, Acanfora C, Ciccone MM, et al. . The cross-talk between thrombosis and inflammatory storm in acute and long-COVID-19: therapeutic targets and clinical cases. Viruses 2021;13(10):1904; doi: 10.3390/v13101904</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13101904</ArticleId><ArticleId IdType="pmc">PMC8540492</ArticleId><ArticleId IdType="pubmed">34696334</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S, Khan MA, Putrino D, et al. . Long COVID: pathophysiological factors and abnormalities of coagulation. Trends Endocrinol Metab 2023;34(6):321&#x2013;344; doi: 10.1016/j.tem.2023.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2023.03.002</ArticleId><ArticleId IdType="pmc">PMC10113134</ArticleId><ArticleId IdType="pubmed">37080828</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan LY, Komarasamy TV, Rmt Balasubramaniam V. Hyperinflammatory immune response and COVID-19: a double edged sword. Front Immunol 2021;12:742941; doi: 10.3389/fimmu.2021.742941</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.742941</ArticleId><ArticleId IdType="pmc">PMC8515020</ArticleId><ArticleId IdType="pubmed">34659238</ArticleId></ArticleIdList></Reference><Reference><Citation>Low RN, Low RJ, Akrami A. A review of cytokine-based pathophysiology of Long COVID symptoms. Front Med (Lausanne) 2023;10:1011936; doi: 10.3389/fmed.2023.1011936</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1011936</ArticleId><ArticleId IdType="pmc">PMC10103649</ArticleId><ArticleId IdType="pubmed">37064029</ArticleId></ArticleIdList></Reference><Reference><Citation>Opsteen S, Files JK, Fram T, et al. . The role of immune activation and antigen persistence in acute and long COVID. J Investig Med 2023;71(5):545&#x2013;562; doi: 10.1177/10815589231158041</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10815589231158041</ArticleId><ArticleId IdType="pmc">PMC9996119</ArticleId><ArticleId IdType="pubmed">36879504</ArticleId></ArticleIdList></Reference><Reference><Citation>Koelman L, Reichmann R, B&#xf6;rnhorst C, et al. . Determinants of elevated chemerin as a novel biomarker of immunometabolism: data from a large population-based cohort. Endocr Connect 2021;10(9):1200&#x2013;1211; doi: 10.1530/ec-21-0273</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/ec-21-0273</ArticleId><ArticleId IdType="pmc">PMC8494416</ArticleId><ArticleId IdType="pubmed">34431786</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss K, Hong HS, Bader JE, et al. . A guide to interrogating immunometabolism. Nat Rev Immunol 2021;21(10):637&#x2013;652; doi: 10.1038/s41577-021-00529-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00529-8</ArticleId><ArticleId IdType="pmc">PMC8478710</ArticleId><ArticleId IdType="pubmed">33859379</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudiansyah M, Jasim SA, Mohammad Pour ZG, et al. . Coronavirus disease 2019 (COVID-19) update: from metabolic reprogramming to immunometabolism. J Med Virol 2022;94(10):4611&#x2013;4627; doi: 10.1002/jmv.27929</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27929</ArticleId><ArticleId IdType="pmc">PMC9350347</ArticleId><ArticleId IdType="pubmed">35689351</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Zeng X, Wang Y, et al. . Immunometabolism and potential targets in severe COVID-19 peripheral immune responses. Asian J Pharm Sci 2021;16(6):665&#x2013;667; doi: 10.1016/j.ajps.2021.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajps.2021.07.001</ArticleId><ArticleId IdType="pmc">PMC8737404</ArticleId><ArticleId IdType="pubmed">35027947</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M, Al-Rubaye HT, Almulla AF, et al. . Lowered quality of life in long COVID is predicted by affective symptoms, chronic fatigue syndrome, inflammation and neuroimmunotoxic pathways. Int J Environ Res Public Health 2022;19(16):10362; doi: 10.3390/ijerph191610362</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191610362</ArticleId><ArticleId IdType="pmc">PMC9408685</ArticleId><ArticleId IdType="pubmed">36011997</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollbracht C, Kraft K. Oxidative stress and hyper-inflammation as major drivers of severe COVID-19 and long COVID: implications for the benefit of high-dose intravenous vitamin C. Front Pharmacol 2022;13:899198; doi: 10.3389/fphar.2022.899198</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.899198</ArticleId><ArticleId IdType="pmc">PMC9100929</ArticleId><ArticleId IdType="pubmed">35571085</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin K, Peluso MJ, Thomas R, et al. . Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2. bioRxiv 2023; doi: 10.1101/2023.02.09.527892</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.02.09.527892</ArticleId><ArticleId IdType="pmc">PMC10834368</ArticleId><ArticleId IdType="pubmed">38212464</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahamed J, Laurence J. Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches. J Clin Invest 2022;132(15):e161167; doi: 10.1172/jci161167</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci161167</ArticleId><ArticleId IdType="pmc">PMC9337829</ArticleId><ArticleId IdType="pubmed">35912863</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherif ZA, Gomez CR, Connors TJ, et al. . Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC). Elife 2023;12:e86002; doi: 10.7554/eLife.86002</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86002</ArticleId><ArticleId IdType="pmc">PMC10032659</ArticleId><ArticleId IdType="pubmed">36947108</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad SJ, Feigen CM, Vazquez JP, et al. . Neurological sequelae of COVID-19. J Integr Neurosci 2022;21(3):77; doi: 10.31083/j.jin2103077</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.jin2103077</ArticleId><ArticleId IdType="pubmed">35633158</ArticleId></ArticleIdList></Reference><Reference><Citation>Acharya Y, Alameer A, Calpin G, et al. . A comprehensive review of vascular complications in COVID-19. J Thromb Thrombolysis 2022;53(3):586&#x2013;593, doi: 10.1007/s11239-021-02593-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-021-02593-2</ArticleId><ArticleId IdType="pmc">PMC8558544</ArticleId><ArticleId IdType="pubmed">34724155</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqi HK, Libby P, Ridker PM. COVID-19&#x2014;a vascular disease. Trends Cardiovasc Med 2021;31(1):1&#x2013;5; doi: 10.1016/j.tcm.2020.10.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2020.10.005</ArticleId><ArticleId IdType="pmc">PMC7556303</ArticleId><ArticleId IdType="pubmed">33068723</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans PC, Rainger GE, Mason JC, et al. . Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science. Cardiovasc Res 2020;116(14):2177&#x2013;2184; doi: 10.1093/cvr/cvaa230</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa230</ArticleId><ArticleId IdType="pmc">PMC7454368</ArticleId><ArticleId IdType="pubmed">32750108</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G, Beghi E. Stroke epidemiology and COVID-19 pandemic. Curr Opin Neurol 2021;34(1):3&#x2013;10; doi: 10.1097/wco.0000000000000879</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/wco.0000000000000879</ArticleId><ArticleId IdType="pubmed">33278139</ArticleId></ArticleIdList></Reference><Reference><Citation>Siepmann T, Sedghi A, Simon E, et al. . Increased risk of acute stroke among patients with severe COVID-19: a multicenter study and meta-analysis. Eur J Neurol 2021;28(1):238&#x2013;247; doi: 10.1111/ene.14535</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14535</ArticleId><ArticleId IdType="pubmed">32920964</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahjouei S, Naderi S, Li J, et al. . Risk of stroke in hospitalized SARS-CoV-2 infected patients: a multinational study. EBioMedicine 2020;59:102939; doi: 10.1016/j.ebiom.2020.102939</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102939</ArticleId><ArticleId IdType="pmc">PMC7429203</ArticleId><ArticleId IdType="pubmed">32818804</ArticleId></ArticleIdList></Reference><Reference><Citation>Fridman S, Bullrich MB, Jimenez-Ruiz A, et al. . Stroke risk, phenotypes, and death in COVID-19: systematic review and newly reported cases. Neurology 2020;95(24):e3373&#x2013;e3385; doi: 10.1212/wnl.0000000000010851</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000010851</ArticleId><ArticleId IdType="pubmed">32934172</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadid T, Kafri Z, Al-Katib A. Coagulation and anticoagulation in COVID-19. Blood Rev 2021;47:100761; doi: 10.1016/j.blre.2020.100761</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.blre.2020.100761</ArticleId><ArticleId IdType="pmc">PMC7543932</ArticleId><ArticleId IdType="pubmed">33067035</ArticleId></ArticleIdList></Reference><Reference><Citation>Astin R, Banerjee A, Baker MR, et al. . Long COVID: mechanisms, risk factors and recovery. Exp Physiol 2023;108(1):12&#x2013;27; doi: 10.1113/ep090802</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/ep090802</ArticleId><ArticleId IdType="pmc">PMC10103775</ArticleId><ArticleId IdType="pubmed">36412084</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Vlok M, Venter C, et al. . Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol 2021;20(1):172; doi: 10.1186/s12933-021-01359-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell DB, Laubscher GJ, Pretorius E. A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications. Biochem J 2022;479(4):537&#x2013;559; doi: 10.1042/bcj20220016</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bcj20220016</ArticleId><ArticleId IdType="pmc">PMC8883497</ArticleId><ArticleId IdType="pubmed">35195253</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D, Chalon P, Kohn L, et al. . Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med 2022;54(1):1473&#x2013;1487; doi: 10.1080/07853890.2022.2076901</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deitchman AN, Torres L, et al. . Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep 2021;36(6):109518; doi: 10.1016/j.celrep.2021.109518</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109518</ArticleId><ArticleId IdType="pmc">PMC8342976</ArticleId><ArticleId IdType="pubmed">34358460</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimohata T. Neuro-COVID-19. Clin Exp Neuroimmunol 2021; doi: 10.1111/cen3.12676</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cen3.12676</ArticleId><ArticleId IdType="pmc">PMC8652810</ArticleId><ArticleId IdType="pubmed">34899999</ArticleId></ArticleIdList></Reference><Reference><Citation>Jentho E, Weis S. DAMPs and Innate Immune Training. Front Immunol 2021;12:699563; doi: 10.3389/fimmu.2021.699563</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.699563</ArticleId><ArticleId IdType="pmc">PMC8569823</ArticleId><ArticleId IdType="pubmed">34745089</ArticleId></ArticleIdList></Reference><Reference><Citation>Klimova EM, Bozhkov AI, Lavinska OV, et al. . Low molecular weight cytotoxic components (DAMPs) form the post-COVID-19 syndrome. Immunobiology 2023;228(1):152316; doi: 10.1016/j.imbio.2022.152316</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2022.152316</ArticleId><ArticleId IdType="pmc">PMC9764760</ArticleId><ArticleId IdType="pubmed">36565610</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam MS, Wang Z, Abdel-Mohsen M, et al. . Tissue injury and leukocyte changes in post-acute sequelae of SARS-CoV-2: review of 2833 post-acute patient outcomes per immune dysregulation and microbial translocation in long COVID. J Leukoc Biol 2023;113(3):236&#x2013;254; doi: 10.1093/jleuko/qiac001</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jleuko/qiac001</ArticleId><ArticleId IdType="pubmed">36807444</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang CS, Ga&#x142;ecki P, Su KP. Unresolved Systemic Inflammation, Long COVID, and the Common Pathomechanisms of Somatic and Psychiatric Comorbidity. J Clin Med 2022;11(17):5114; doi: 10.3390/jcm11175114</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11175114</ArticleId><ArticleId IdType="pmc">PMC9457285</ArticleId><ArticleId IdType="pubmed">36079040</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano GB, B&#xfc;ttiker P, Weissenberger S, et al. . Editorial: the pathogenesis of long-term neuropsychiatric COVID-19 and the role of microglia, mitochondria, and persistent neuroinflammation: a hypothesis. Med Sci Monit 2021;27:e933015; doi: 10.12659/msm.933015</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/msm.933015</ArticleId><ArticleId IdType="pmc">PMC8120907</ArticleId><ArticleId IdType="pubmed">34016942</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen M. Brain imaging and neuropsychological assessment of individuals recovered from a mild to moderate SARS- CoV-2 infection. medRxiv 2022; doi: &lt;h/&gt; 10.1101/2022.07.08.22277420</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.07.08.22277420</ArticleId><ArticleId IdType="pmc">PMC10235949</ArticleId><ArticleId IdType="pubmed">37220275</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen MS, Kristiansen MF, Hanusson KD, et al. . Prevalence of long COVID in a national cohort: longitudinal measures from disease onset until 8 months' follow-up. Int J Infect Dis 2022;122:437&#x2013;441; doi: 10.1016/j.ijid.2022.06.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.06.031</ArticleId><ArticleId IdType="pmc">PMC9222150</ArticleId><ArticleId IdType="pubmed">35753603</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Rhermoul FZ, Fedorowski A, Eardley P, et al. . Autoimmunity in Long Covid and POTS. Oxf Open Immunol 2023;4(1):iqad002; doi: 10.1093/oxfimm/iqad002</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfimm/iqad002</ArticleId><ArticleId IdType="pmc">PMC10224806</ArticleId><ArticleId IdType="pubmed">37255928</ArticleId></ArticleIdList></Reference><Reference><Citation>Sin DD. Is long COVID an autoimmune disease? Eur Respir J 2023;61(1):2202272; doi: 10.1183/13993003.02272-2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02272-2022</ArticleId><ArticleId IdType="pubmed">36634924</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaya JM, Herr&#xe1;n M, Beltr&#xe1;n S, et al. . Is post-COVID syndrome an autoimmune disease? Expert Rev Clin Immunol 2022;18(7):653&#x2013;666; doi: 10.1080/1744666x.2022.2085561</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666x.2022.2085561</ArticleId><ArticleId IdType="pubmed">35658801</ArticleId></ArticleIdList></Reference><Reference><Citation>Votto M, Castagnoli R, Marseglia GL, et al. . COVID-19 and autoimmune diseases: is there a connection? Curr Opin Allergy Clin Immunol 2023;23(2):185&#x2013;192; doi: 10.1097/aci.0000000000000888</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/aci.0000000000000888</ArticleId><ArticleId IdType="pubmed">36728317</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke C, Boesl F, Goereci Y, et al. . Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome. Brain Behav Immun 2023;109:139&#x2013;143; doi: 10.1016/j.bbi.2023.01.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2023.01.006</ArticleId><ArticleId IdType="pmc">PMC9841734</ArticleId><ArticleId IdType="pubmed">36657623</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham E. Brain Injury in COVID-19 is Associated with Autoinflammation and Autoimmunity. medRxiv 2021; doi: 10.1101/2021.12.03.21266112</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.12.03.21266112</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham EJ, Chou SH, Coles AJ, et al. . Neurological implications of COVID-19 infections. Neurocrit Care 2020;32(3):667&#x2013;671; doi: 10.1007/s12028-020-00978-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12028-020-00978-4</ArticleId><ArticleId IdType="pmc">PMC7188454</ArticleId><ArticleId IdType="pubmed">32346843</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham EJ, Ren AL, Digby RJ, et al. . Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses. Brain 2022;145(11):4097&#x2013;4107; doi: 10.1093/brain/awac321</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac321</ArticleId><ArticleId IdType="pmc">PMC9494359</ArticleId><ArticleId IdType="pubmed">36065116</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindqvist I, Cunningham JL, Mulder J, et al. . Myoclonus in patients with COVID-19: Findings of autoantibodies against brain structures in cerebrospinal fluid. Eur J Neurol 2023; doi: 10.1111/ene.15958</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15958</ArticleId><ArticleId IdType="pubmed">37392418</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwak N, Lee KH, Woo J, et al. . Synergistic cycles of protease activity and inflammation via PPAR&#x3b3; degradation in chronic obstructive pulmonary disease. Exp Mol Med 2021;53(5):947&#x2013;955; doi: 10.1038/s12276-021-00626-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-021-00626-7</ArticleId><ArticleId IdType="pmc">PMC8178386</ArticleId><ArticleId IdType="pubmed">34021254</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L, Zhao J, Zhong K, et al. . Targeted protein degradation: mechanisms, strategies and application. Signal Transduct Target Ther 2022;7(1):113; doi: 10.1038/s41392-022-00966-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00966-4</ArticleId><ArticleId IdType="pmc">PMC8977435</ArticleId><ArticleId IdType="pubmed">35379777</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkataramani V, Winkler F. Cognitive deficits in Long Covid-19. N Engl J Med 2022;387(19):1813&#x2013;1815; doi: 10.1056/NEJMcibr2210069</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcibr2210069</ArticleId><ArticleId IdType="pubmed">36351274</ArticleId></ArticleIdList></Reference><Reference><Citation>Agoston DV, Elsayed M. Serum-based protein biomarkers in blast-induced traumatic brain injury spectrum disorder. Front Neurol 2012;3:107; doi: 10.3389/fneur.2012.00107</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2012.00107</ArticleId><ArticleId IdType="pmc">PMC3390892</ArticleId><ArticleId IdType="pubmed">22783223</ArticleId></ArticleIdList></Reference><Reference><Citation>Bremner JD, Wittbrodt MT. Stress, the brain, and trauma spectrum disorders. Int Rev Neurobiol 2020;152:1&#x2013;22; doi: 10.1016/bs.irn.2020.01.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.irn.2020.01.004</ArticleId><ArticleId IdType="pmc">PMC8214870</ArticleId><ArticleId IdType="pubmed">32450992</ArticleId></ArticleIdList></Reference><Reference><Citation>Decuypere M, Klimo P Jr. Spectrum of traumatic brain injury from mild to severe. Surg Clin North Am 2012;92(4):939&#x2013;957, ix; doi: 10.1016/j.suc.2012.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.suc.2012.04.005</ArticleId><ArticleId IdType="pubmed">22850156</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan BD. The clinical spectrum of sport-related traumatic brain injury. Nat Rev Neurol 2013;9(4):222&#x2013;230; doi: 10.1038/nrneurol.2013.33</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.33</ArticleId><ArticleId IdType="pubmed">23478462</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer AR, Quinn DK, Master CL. The spectrum of mild traumatic brain injury: A review. Neurology 2017;89(6):623&#x2013;632; doi: 10.1212/wnl.0000000000004214</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000004214</ArticleId><ArticleId IdType="pmc">PMC5562956</ArticleId><ArticleId IdType="pubmed">28701496</ArticleId></ArticleIdList></Reference><Reference><Citation>Pugh MJ, Kennedy E, Prager EM, et al. . Phenotyping the spectrum of traumatic brain injury: a review and pathway to standardization. J Neurotrauma 2021;38(23):3222&#x2013;3234; doi: 10.1089/neu.2021.0059</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2021.0059</ArticleId><ArticleId IdType="pmc">PMC8917880</ArticleId><ArticleId IdType="pubmed">33858210</ArticleId></ArticleIdList></Reference><Reference><Citation>Si B, Dumkrieger G, Wu T, et al. . Sub-classifying patients with mild traumatic brain injury: a clustering approach based on baseline clinical characteristics and 90-day and 180-day outcomes. PLoS One 2018;13(7):e0198741; doi: 10.1371/journal.pone.0198741</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0198741</ArticleId><ArticleId IdType="pmc">PMC6040703</ArticleId><ArticleId IdType="pubmed">29995912</ArticleId></ArticleIdList></Reference><Reference><Citation>Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974;2(7872):81&#x2013;84; doi: 10.1016/s0140-6736(74)91639-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(74)91639-0</ArticleId><ArticleId IdType="pubmed">4136544</ArticleId></ArticleIdList></Reference><Reference><Citation>Dikmen S, Machamer J, Manley GT, et al. ; TRACK-TBI Investigators. Functional Status Examination versus Glasgow Outcome Scale Extended as outcome measures in traumatic brain injuries: how do they compare? J Neurotrauma 2019;36(16):2423&#x2013;2429; doi: 10.1089/neu.2018.6198</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2018.6198</ArticleId><ArticleId IdType="pmc">PMC6661915</ArticleId><ArticleId IdType="pubmed">30827167</ArticleId></ArticleIdList></Reference><Reference><Citation>Reith FC, Synnot A, van den Brande R, et al. . Factors influencing the reliability of the Glasgow Coma Scale: a systematic review. Neurosurgery 2017;80(6):829&#x2013;839; doi: 10.1093/neuros/nyw178</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/neuros/nyw178</ArticleId><ArticleId IdType="pubmed">28327922</ArticleId></ArticleIdList></Reference><Reference><Citation>Reith FC, Van den Brande R, Synnot A, et al. . The reliability of the Glasgow Coma Scale: a systematic review. Intensive Care Med 2016;42(1):3&#x2013;15; doi: 10.1007/s00134-015-4124-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-4124-3</ArticleId><ArticleId IdType="pubmed">26564211</ArticleId></ArticleIdList></Reference><Reference><Citation>Segatore M, Way C. The Glasgow Coma Scale: time for change. Heart Lung 1992;21(6):548&#x2013;557.</Citation><ArticleIdList><ArticleId IdType="pubmed">1447002</ArticleId></ArticleIdList></Reference><Reference><Citation>Giza C, Greco T, Prins ML. Concussion: pathophysiology and clinical translation. Handb Clin Neurol 2018;158:51&#x2013;61; doi: 10.1016/b978-0-444-63954-7.00006-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/b978-0-444-63954-7.00006-9</ArticleId><ArticleId IdType="pubmed">30482375</ArticleId></ArticleIdList></Reference><Reference><Citation>Echemendia RJ, Meeuwisse W, McCrory P, et al. . The Sport Concussion Assessment Tool 5th Edition (SCAT5): background and rationale. Br J Sports Med 2017;51(11):848&#x2013;850; doi: 10.1136/bjsports-2017-097506</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjsports-2017-097506</ArticleId><ArticleId IdType="pubmed">28446453</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasrallah F, Bellapart J, Walsham J, et al. . PREdiction and Diagnosis using Imaging and Clinical biomarkers Trial in Traumatic Brain Injury (PREDICT-TBI) study protocol: an observational, prospective, multicentre cohort study for the prediction of outcome in moderate-to-severe TBI. BMJ Open 2023;13(4):e067740; doi: 10.1136/bmjopen-2022-067740</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-067740</ArticleId><ArticleId IdType="pmc">PMC10151972</ArticleId><ArticleId IdType="pubmed">37094888</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi CE, Virmani D, Chung DY, et al. . Blunt and penetrating severe traumatic brain injury. Neurol Clin 2021;39(2):443&#x2013;469; doi: 10.1016/j.ncl.2021.02.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2021.02.009</ArticleId><ArticleId IdType="pubmed">33896528</ArticleId></ArticleIdList></Reference><Reference><Citation>Dijkland SA, Foks KA, Polinder S, et al. . Prognosis in moderate and severe traumatic brain injury: a systematic review of contemporary models and validation studies. J Neurotrauma 2020;37(1):1&#x2013;13; doi: 10.1089/neu.2019.6401</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2019.6401</ArticleId><ArticleId IdType="pubmed">31099301</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelmalik PA, Draghic N, Ling GSF. Management of moderate and severe traumatic brain injury. Transfusion 2019;59(S2):1529&#x2013;1538; doi: 10.1111/trf.15171</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.15171</ArticleId><ArticleId IdType="pubmed">30980755</ArticleId></ArticleIdList></Reference><Reference><Citation>Stocchetti N, Carbonara M, Citerio G, et al. . Severe traumatic brain injury: targeted management in the intensive care unit. Lancet Neurol 2017;16(6):452&#x2013;464; doi: 10.1016/s1474-4422(17)30118-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(17)30118-7</ArticleId><ArticleId IdType="pubmed">28504109</ArticleId></ArticleIdList></Reference><Reference><Citation>Golding EM. Sequelae following traumatic brain injury. The cerebrovascular perspective. Brain Res Brain Res Rev 2002;38(3):377&#x2013;388.</Citation><ArticleIdList><ArticleId IdType="pubmed">11890983</ArticleId></ArticleIdList></Reference><Reference><Citation>Papa L, Brophy GM, Welch RD, et al. . Time course and diagnostic accuracy of glial and neuronal blood biomarkers GFAP and UCH-L1 in a large cohort of trauma patients with and without mild traumatic brain injury. JAMA Neurol 2016;73(5):551&#x2013;560; doi: 10.1001/jamaneurol.2016.0039</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2016.0039</ArticleId><ArticleId IdType="pmc">PMC8805143</ArticleId><ArticleId IdType="pubmed">27018834</ArticleId></ArticleIdList></Reference><Reference><Citation>Rostami E, Gyorgy A, Davidsson J, et al. . Time-dependent changes in serum level of protein biomarkers after focal traumatic brain injury. Int J Neurorehabilitation 2015;2(3):2&#x2013;6.</Citation></Reference><Reference><Citation>Agoston DV, Vink B, Helmy A, et al. . How to translate time; the temporal aspects of rodent and human pathobiological processes in traumatic brain injury. J Neurotrauma 2019;36(11):1724&#x2013;1737; doi: 10.1089/neu.2018.6261</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2018.6261</ArticleId><ArticleId IdType="pmc">PMC7643768</ArticleId><ArticleId IdType="pubmed">30628544</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed F, Gyorgy A, Kamnaksh A, et al. . Time-dependent changes of protein biomarker levels in the cerebrospinal fluid after blast traumatic brain injury. Electrophoresis 2012;33(24):3705&#x2013;3711; doi: 10.1002/elps.201200299</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/elps.201200299</ArticleId><ArticleId IdType="pubmed">23161535</ArticleId></ArticleIdList></Reference><Reference><Citation>Gyorgy A, Ling G, Wingo D, et al. . Time-dependent changes in serum biomarker levels after blast traumatic brain injury. J Neurotrauma 2011;28(6):1121&#x2013;1126; doi: 10.1089/neu.2010.1561</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2010.1561</ArticleId><ArticleId IdType="pubmed">21428721</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin IH, Kamnaksh A, Aniceto R, et al. . Time-dependent changes in the biofluid levels of neural injury markers in severe traumatic brain injury patients&#x2014;cerebrospinal fluid and cerebral microdialysates: a longitudinal prospective pilot study. Neurotrauma Rep 2023;4(1):107&#x2013;117; doi: 10.1089/neur.2022.0076</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neur.2022.0076</ArticleId><ArticleId IdType="pmc">PMC9989523</ArticleId><ArticleId IdType="pubmed">36895820</ArticleId></ArticleIdList></Reference><Reference><Citation>Thelin EP, Zeiler FA, Ercole A, et al. . Serial sampling of serum protein biomarkers for monitoring human traumatic brain injury dynamics: a systematic review. Front Neurol 2017;8:300; doi: 10.3389/fneur.2017.00300</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2017.00300</ArticleId><ArticleId IdType="pmc">PMC5494601</ArticleId><ArticleId IdType="pubmed">28717351</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamadpour M, Whitney K, Bergold PJ. The importance of therapeutic time window in the treatment of traumatic brain injury. Front Neurosci 2019;13:07; doi: 10.3389/fnins.2019.00007</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00007</ArticleId><ArticleId IdType="pmc">PMC6351484</ArticleId><ArticleId IdType="pubmed">30728762</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamins J, Bigler E, Covassin T, et al. . What is the physiological time to recovery after concussion? A systematic review. Br J Sports Med 2017;51(12):935&#x2013;940; doi: 10.1136/bjsports-2016-097464</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjsports-2016-097464</ArticleId><ArticleId IdType="pubmed">28455363</ArticleId></ArticleIdList></Reference><Reference><Citation>Balan&#xe7;a B, Desmurs L, Grelier J, et al. . DAMPs and RAGE pathophysiology at the acute phase of brain injury: an overview. Int J Mol Sci 2021;22(5):2439; doi: 10.3390/ijms22052439</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22052439</ArticleId><ArticleId IdType="pmc">PMC7957733</ArticleId><ArticleId IdType="pubmed">33670976</ArticleId></ArticleIdList></Reference><Reference><Citation>Liesz A, Dalpke A, Mracsko E, et al. . DAMP signaling is a key pathway inducing immune modulation after brain injury. J Neurosci 2015;35(2):583&#x2013;598; doi: 10.1523/jneurosci.2439-14.2015</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/jneurosci.2439-14.2015</ArticleId><ArticleId IdType="pmc">PMC4293412</ArticleId><ArticleId IdType="pubmed">25589753</ArticleId></ArticleIdList></Reference><Reference><Citation>Thundyil J, Lim KL. DAMPs and neurodegeneration. Ageing Res Rev 2015;24(Pt A):17&#x2013;28; doi: 10.1016/j.arr.2014.11.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2014.11.003</ArticleId><ArticleId IdType="pubmed">25462192</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsitsopoulos PP, Abu Hamdeh S, Marklund N. Current opportunities for clinical monitoring of axonal pathology in traumatic brain injury. Front Neurol 2017;8:599; doi: 10.3389/fneur.2017.00599</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2017.00599</ArticleId><ArticleId IdType="pmc">PMC5702013</ArticleId><ArticleId IdType="pubmed">29209266</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith DH, Nonaka M, Miller R, et al. . Immediate coma following inertial brain injury dependent on axonal damage in the brainstem. J Neurosurg 2000;93(2):315&#x2013;322; doi: 10.3171/jns.2000.93.2.0315</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/jns.2000.93.2.0315</ArticleId><ArticleId IdType="pubmed">10930019</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson VE, Stewart W, Smith DH. Axonal pathology in traumatic brain injury. Exp Neurol 2013;246:35&#x2013;43; doi: 10.1016/j.expneurol.2012.01.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2012.01.013</ArticleId><ArticleId IdType="pmc">PMC3979341</ArticleId><ArticleId IdType="pubmed">22285252</ArticleId></ArticleIdList></Reference><Reference><Citation>Povlishock JT, Erb DE, Astruc J. Axonal response to traumatic brain injury: reactive axonal change, deafferentation, and neuroplasticity. J Neurotrauma 1992;9(Suppl 1):S189&#x2013;S200.</Citation><ArticleIdList><ArticleId IdType="pubmed">1588608</ArticleId></ArticleIdList></Reference><Reference><Citation>Haber M, Amyot F, Lynch CE, et al. . Imaging biomarkers of vascular and axonal injury are spatially distinct in chronic traumatic brain injury. J Cereb Blood Flow Metab 2021; doi: 10.1177/0271678x20985156</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0271678x20985156</ArticleId><ArticleId IdType="pmc">PMC8327117</ArticleId><ArticleId IdType="pubmed">33444092</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenney K, Amyot F, Haber M, et al. . Cerebral vascular injury in traumatic brain injury. Exp Neurol 2016;275 Pt 3:353&#x2013;366; doi: 10.1016/j.expneurol.2015.05.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.05.019</ArticleId><ArticleId IdType="pubmed">26048614</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch CE, Eisenbaum M, Algamal M, et al. . Impairment of cerebrovascular reactivity in response to hypercapnic challenge in a mouse model of repetitive mild traumatic brain injury. J Cereb Blood Flow Metab 2020; doi: 10.1177/0271678x20954015</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0271678x20954015</ArticleId><ArticleId IdType="pmc">PMC8142124</ArticleId><ArticleId IdType="pubmed">33050825</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandsmark DK, Bashir A, Wellington CL, et al. . Cerebral microvascular injury: a potentially treatable endophenotype of traumatic brain injury-induced neurodegeneration. Neuron 2019;103(3):367&#x2013;379; doi: 10.1016/j.neuron.2019.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.06.002</ArticleId><ArticleId IdType="pmc">PMC6688649</ArticleId><ArticleId IdType="pubmed">31394062</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider ALC, Barber J, Temkin N, et al. . Associations of preexisting vascular risk factors with outcomes after traumatic brain injury: a TRACK-TBI study. J Head Trauma Rehabil 2023;38(2):e88&#x2013;e98; doi: 10.1097/htr.0000000000000798</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/htr.0000000000000798</ArticleId><ArticleId IdType="pmc">PMC9732141</ArticleId><ArticleId IdType="pubmed">35687893</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker TL, Agoston DV, Brady RD, et al. . Targeting the cerebrovascular system: next-generation biomarkers and treatment for mild traumatic brain injury. Neuroscientist 2021; doi: 10.1177/10738584211012264</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10738584211012264</ArticleId><ArticleId IdType="pubmed">33966527</ArticleId></ArticleIdList></Reference><Reference><Citation>Werhane ML, Evangelista ND, Clark AL, et al. . Pathological vascular and inflammatory biomarkers of acute- and chronic-phase traumatic brain injury. Concussion 2017;2(1):Cnc30; doi: 10.2217/cnc-2016-0022</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/cnc-2016-0022</ArticleId><ArticleId IdType="pmc">PMC6094091</ArticleId><ArticleId IdType="pubmed">30202571</ArticleId></ArticleIdList></Reference><Reference><Citation>Amyot F, Kenney K, Moore C, et al. . Imaging of cerebrovascular function in chronic traumatic brain injury. J Neurotrauma 2018;35(10):1116&#x2013;1123; doi: 10.1089/neu.2017.5114</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2017.5114</ArticleId><ArticleId IdType="pmc">PMC6016094</ArticleId><ArticleId IdType="pubmed">29065769</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun M, Symons GF, O'Brien WT, et al. . Serum protein biomarkers of inflammation, oxidative stress, and cerebrovascular and glial injury in concussed Australian football players. J Neurotrauma 2022;39(11&#x2013;12):800&#x2013;808; doi: 10.1089/neu.2021.0493</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2021.0493</ArticleId><ArticleId IdType="pubmed">35176905</ArticleId></ArticleIdList></Reference><Reference><Citation>Major BP, McDonald SJ, O'Brien WT, et al. . Serum protein biomarker findings reflective of oxidative stress and vascular abnormalities in male, but not female, collision sport athletes. Front Neurol 2020;11:549624; doi: 10.3389/fneur.2020.549624</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.549624</ArticleId><ArticleId IdType="pmc">PMC7561422</ArticleId><ArticleId IdType="pubmed">33117257</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright DK, Brady RD, Kamnaksh A, et al. . Repeated mild traumatic brain injuries induce persistent changes in plasma protein and magnetic resonance imaging biomarkers in the rat. Sci Rep 2019;9(1):14626; doi: 10.1038/s41598-019-51267-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-51267-w</ArticleId><ArticleId IdType="pmc">PMC6787341</ArticleId><ArticleId IdType="pubmed">31602002</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas R, Gatson J, Silverman E, et al. . von Willebrand factor as a biomarker of traumatic brain injury. Neurology 2021;96(15 Supplement):4717.</Citation></Reference><Reference><Citation>Sandsmark DK, Bogoslovsky T, Qu BX, et al. . Changes in plasma von Willebrand factor and cellular fibronectin in MRI-defined traumatic microvascular injury. Front Neurol 2019;10:246; doi: 10.3389/fneur.2019.00246</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00246</ArticleId><ArticleId IdType="pmc">PMC6445052</ArticleId><ArticleId IdType="pubmed">30972003</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempuraj D, Ahmed ME, Selvakumar GP, et al. . Mast cell activation, neuroinflammation, and tight junction protein derangement in acute traumatic brain injury. Mediators Inflamm 2020;2020:4243953; doi: 10.1155/2020/4243953</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/4243953</ArticleId><ArticleId IdType="pmc">PMC7333064</ArticleId><ArticleId IdType="pubmed">32684835</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhowmick S, D'Mello V, Caruso D, et al. . Impairment of pericyte-endothelium crosstalk leads to blood-brain barrier dysfunction following traumatic brain injury. Exp Neurol 2019;317:260&#x2013;270; doi: 10.1016/j.expneurol.2019.03.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2019.03.014</ArticleId><ArticleId IdType="pubmed">30926390</ArticleId></ArticleIdList></Reference><Reference><Citation>Hubbard WB, Dong JF, Cruz MA, et al. . Links between thrombosis and inflammation in traumatic brain injury. Thromb Res 2021;198:62&#x2013;71; doi: 10.1016/j.thromres.2020.10.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.10.041</ArticleId><ArticleId IdType="pmc">PMC7867616</ArticleId><ArticleId IdType="pubmed">33290884</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempuraj D, Ahmed ME, Selvakumar GP, et al. . Acute traumatic brain injury-induced neuroinflammatory response and neurovascular disorders in the brain. Neurotox Res 2021;39(2):359&#x2013;368; doi: 10.1007/s12640-020-00288-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-020-00288-9</ArticleId><ArticleId IdType="pmc">PMC7502806</ArticleId><ArticleId IdType="pubmed">32955722</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulhan S, Lyon KA, Shapiro LA, et al. . Neuroinflammation and blood-brain barrier disruption following traumatic brain injury: pathophysiology and potential therapeutic targets. J Neurosci Res 2020;98(1):19&#x2013;28; doi: 10.1002/jnr.24331</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.24331</ArticleId><ArticleId IdType="pmc">PMC6437022</ArticleId><ArticleId IdType="pubmed">30259550</ArticleId></ArticleIdList></Reference><Reference><Citation>Frederick N, Louveau A. Meningeal lymphatics, immunity and neuroinflammation. Curr Opin Neurobiol 2020;62:41&#x2013;47; doi: 10.1016/j.conb.2019.11.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2019.11.010</ArticleId><ArticleId IdType="pubmed">31816570</ArticleId></ArticleIdList></Reference><Reference><Citation>Thelin EP, Tajsic T, Zeiler FA, et al. . Monitoring the neuroinflammatory response following acute brain injury. Front Neurol 2017;8:351; doi: 10.3389/fneur.2017.00351</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2017.00351</ArticleId><ArticleId IdType="pmc">PMC5517395</ArticleId><ArticleId IdType="pubmed">28775710</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham EJ, Helmy A, Zanier ER, et al. . The immunological response to traumatic brain injury. J Neuroimmunol 2019;332:112&#x2013;125; doi: 10.1016/j.jneuroim.2019.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2019.04.005</ArticleId><ArticleId IdType="pubmed">31005712</ArticleId></ArticleIdList></Reference><Reference><Citation>Medzhitov R. Origin and physiological roles of inflammation. Nature 2008;454(7203):428&#x2013;435; doi: 10.1038/nature07201</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature07201</ArticleId><ArticleId IdType="pubmed">18650913</ArticleId></ArticleIdList></Reference><Reference><Citation>McGinn MJ, Povlishock JT. Pathophysiology of traumatic brain injury. Neurosurg Clin N Am 2016;27(4):397&#x2013;407; doi: 10.1016/j.nec.2016.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nec.2016.06.002</ArticleId><ArticleId IdType="pubmed">27637392</ArticleId></ArticleIdList></Reference><Reference><Citation>Marklund N, Vedung F, Lubberink M, et al. . Tau aggregation and increased neuroinflammation in athletes after sports-related concussions and in traumatic brain injury patients&#x2014;a PET/MR study. Neuroimage Clin 2021;30:102665; doi: 10.1016/j.nicl.2021.102665</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2021.102665</ArticleId><ArticleId IdType="pmc">PMC8091173</ArticleId><ArticleId IdType="pubmed">33894460</ArticleId></ArticleIdList></Reference><Reference><Citation>Nitta ME, Savitz J, Nelson LD, et al. . Acute elevation of serum inflammatory markers predicts symptom recovery after concussion. Neurology 2019;93(5):e497&#x2013;e507; doi: 10.1212/wnl.0000000000007864</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000007864</ArticleId><ArticleId IdType="pmc">PMC6693429</ArticleId><ArticleId IdType="pubmed">31270219</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry VH, Teeling J. Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration. Semin Immunopathol 2013;35(5):601&#x2013;612; doi: 10.1007/s00281-013-0382-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-013-0382-8</ArticleId><ArticleId IdType="pmc">PMC3742955</ArticleId><ArticleId IdType="pubmed">23732506</ArticleId></ArticleIdList></Reference><Reference><Citation>Linnerbauer M, Wheeler MA, Quintana FJ. Astrocyte crosstalk in CNS inflammation. Neuron 2020;108(4):608&#x2013;622; doi: 10.1016/j.neuron.2020.08.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.08.012</ArticleId><ArticleId IdType="pmc">PMC7704785</ArticleId><ArticleId IdType="pubmed">32898475</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhusal A, Afridi R, Lee WH, et al. . Bidirectional communication between microglia and astrocytes in neuroinflammation. Curr Neuropharmacol 2023;21(10):2020&#x2013;2029; doi: 10.2174/1570159x21666221129121715</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159x21666221129121715</ArticleId><ArticleId IdType="pmc">PMC10556371</ArticleId><ArticleId IdType="pubmed">36453496</ArticleId></ArticleIdList></Reference><Reference><Citation>Patani R, Hardingham GE, Liddelow SA. Functional roles of reactive astrocytes in neuroinflammation and neurodegeneration. Nat Rev Neurol 2023;19(7):395&#x2013;409; doi: 10.1038/s41582-023-00822-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-023-00822-1</ArticleId><ArticleId IdType="pubmed">37308616</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang KK, Yang Z, Yue JK, et al. . Plasma anti-glial fibrillary acidic protein autoantibody levels during the acute and chronic phases of traumatic brain injury: a Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot Study. J Neurotrauma 2016;33(13):1270&#x2013;1277; doi: 10.1089/neu.2015.3881</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2015.3881</ArticleId><ArticleId IdType="pmc">PMC4931336</ArticleId><ArticleId IdType="pubmed">26560343</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham EJ, Stoevesandt O, Thelin EP, et al. . Complex autoantibody responses occur following moderate to severe traumatic brain injury. J Immunol 2021;207(1):90&#x2013;100; doi: 10.4049/jimmunol.2001309</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2001309</ArticleId><ArticleId IdType="pubmed">34145056</ArticleId></ArticleIdList></Reference><Reference><Citation>Tisminetzky M, Delude C, Hebert T, et al. . Age, multiple chronic conditions, and COVID-19: a literature review. J Gerontol A Biol Sci Med Sci 2022;77(4):872&#x2013;878; doi: 10.1093/gerona/glaa320</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glaa320</ArticleId><ArticleId IdType="pmc">PMC7799222</ArticleId><ArticleId IdType="pubmed">33367606</ArticleId></ArticleIdList></Reference><Reference><Citation>Polidori MC, Sies H, Ferrucci L, et al. . COVID-19 mortality as a fingerprint of biological age. Ageing Res Rev 2021;67:101308; doi: 10.1016/j.arr.2021.101308</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2021.101308</ArticleId><ArticleId IdType="pmc">PMC7896489</ArticleId><ArticleId IdType="pubmed">33621704</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, de Oliveira MHS, Peligro PJ, et al. . Age, sex and previous comorbidities as risk factors not associated with SARS-CoV-2 infection for long COVID-19: a systematic review and meta-analysis. J Clin Med 2022;11(24):7314; doi: 10.3390/jcm11247314</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11247314</ArticleId><ArticleId IdType="pmc">PMC9787827</ArticleId><ArticleId IdType="pubmed">36555931</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, Shafran R, Ladhani SN. Long COVID in children and adolescents. Curr Opin Infect Dis 2022;35(5):461&#x2013;467; doi: 10.1097/qco.0000000000000854</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/qco.0000000000000854</ArticleId><ArticleId IdType="pmc">PMC9553244</ArticleId><ArticleId IdType="pubmed">36098262</ArticleId></ArticleIdList></Reference><Reference><Citation>Brugler Yonts A. Pediatric Long-COVID: a review of the definition, epidemiology, presentation, and pathophysiology. Pediatr Ann 2022;51(11):e416&#x2013;e420; doi: 10.3928/19382359-20220913-06</Citation><ArticleIdList><ArticleId IdType="doi">10.3928/19382359-20220913-06</ArticleId><ArticleId IdType="pubmed">36343180</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters ME, Hsu M, Rao V, et al. . Influence of study population definition on the effect of age on outcomes after blunt head trauma. Brain Inj 2018;32(13&#x2013;14):1725&#x2013;1730; doi: 10.1080/02699052.2018.1520301</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02699052.2018.1520301</ArticleId><ArticleId IdType="pmc">PMC6480396</ArticleId><ArticleId IdType="pubmed">30230916</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer AR, Meier TB, Dodd AB, et al. . Prospective study of gray matter atrophy following pediatric mild traumatic brain injury. Neurology 2023;100(5):e516&#x2013;e527; doi: 10.1212/wnl.0000000000201470</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000201470</ArticleId><ArticleId IdType="pmc">PMC9931084</ArticleId><ArticleId IdType="pubmed">36522161</ArticleId></ArticleIdList></Reference><Reference><Citation>Keenan HT, Hooper SR, Wetherington CE, et al. . Neurodevelopmental consequences of early traumatic brain injury in 3-year-old children. Pediatrics 2007;119(3):e616&#x2013;e623; doi: 10.1542/peds.2006-2313</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2006-2313</ArticleId><ArticleId IdType="pmc">PMC2361427</ArticleId><ArticleId IdType="pubmed">17332181</ArticleId></ArticleIdList></Reference><Reference><Citation>Koerte IK, Wiegand TLT, Bonke EM, et al. . Diffusion imaging of sport-related repetitive head impacts&#x2014;a systematic review. Neuropsychol Rev 2023;33(1):122&#x2013;143; doi: 10.1007/s11065-022-09566-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11065-022-09566-z</ArticleId><ArticleId IdType="pmc">PMC9998592</ArticleId><ArticleId IdType="pubmed">36508043</ArticleId></ArticleIdList></Reference><Reference><Citation>Badea A, Kamnaksh A, Anderson RJ, et al. . Repeated mild blast exposure in young adult rats results in dynamic and persistent microstructural changes in the brain. Neuroimage Clin 2018;18:60&#x2013;73; doi: 10.1016/j.nicl.2018.01.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2018.01.007</ArticleId><ArticleId IdType="pmc">PMC5984602</ArticleId><ArticleId IdType="pubmed">29868442</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher-Sandersjoo A, Lindblad C, Thelin EP, et al. . Serial S100B sampling detects intracranial lesion development in patients on extracorporeal membrane oxygenation. Front Neurol 2019;10:512; doi: 10.3389/fneur.2019.00512</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00512</ArticleId><ArticleId IdType="pmc">PMC6532588</ArticleId><ArticleId IdType="pubmed">31156541</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsilingiris D, Vallianou NG, Karampela I, et al. . Laboratory findings and biomarkers in Long COVID: what do we know so far? Insights into epidemiology, pathogenesis, therapeutic perspectives and challenges. Int J Mol Sci 2023;24(13):10458; doi: 10.3390/ijms241310458</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241310458</ArticleId><ArticleId IdType="pmc">PMC10341908</ArticleId><ArticleId IdType="pubmed">37445634</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L, Shan W, Yang H, et al. . The role of neuroinflammation in post-traumatic epilepsy. Front Neurol 2021;12:646152; doi: 10.3389/fneur.2021.646152</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.646152</ArticleId><ArticleId IdType="pmc">PMC8194282</ArticleId><ArticleId IdType="pubmed">34122298</ArticleId></ArticleIdList></Reference><Reference><Citation>Folweiler KA, Sandsmark DK, Diaz-Arrastia R, et al. . Unsupervised machine learning reveals novel traumatic brain injury patient phenotypes with distinct acute injury profiles and long-term outcomes. J Neurotrauma 2020;37(12):1431&#x2013;1444; doi: 10.1089/neu.2019.6705</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2019.6705</ArticleId><ArticleId IdType="pmc">PMC7249479</ArticleId><ArticleId IdType="pubmed">32008422</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayed N, Culver C, Dams-O'Connor K, et al. . Clinical phenotype of dementia after traumatic brain injury. J Neurotrauma 2013;30(13):1117&#x2013;1122; doi: 10.1089/neu.2012.2638</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2012.2638</ArticleId><ArticleId IdType="pmc">PMC3705947</ArticleId><ArticleId IdType="pubmed">23374007</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Arrastia R, Agostini MA, Madden CJ, et al. . Posttraumatic epilepsy: the endophenotypes of a human model of epileptogenesis. Epilepsia 2009;50(Suppl 2):14&#x2013;20; doi: 10.1111/j.1528-1167.2008.02006.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1528-1167.2008.02006.x</ArticleId><ArticleId IdType="pubmed">19187290</ArticleId></ArticleIdList></Reference><Reference><Citation>Agoston DV, Shutes-David A, Peskind ER. Biofluid biomarkers of traumatic brain injury. Brain Inj 2017;31(9):1195&#x2013;1203; doi: 10.1080/02699052.2017.1357836</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02699052.2017.1357836</ArticleId><ArticleId IdType="pubmed">28981341</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang KK, Yang Z, Zhu T, et al. . An update on diagnostic and prognostic biomarkers for traumatic brain injury. Expert Rev Mol Diagn 2018;18(2):165&#x2013;180; doi: 10.1080/14737159.2018.1428089</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737159.2018.1428089</ArticleId><ArticleId IdType="pmc">PMC6359936</ArticleId><ArticleId IdType="pubmed">29338452</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondello S, Sorinola A, Czeiter E, et al. . Blood-based protein biomarkers for the management of traumatic brain injuries in adults presenting to emergency departments with mild brain injury: a living systematic review and meta-analysis. J Neurotrauma 2021;38(8):1086&#x2013;1106; doi: 10.1089/neu.2017.5182</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2017.5182</ArticleId><ArticleId IdType="pmc">PMC8054517</ArticleId><ArticleId IdType="pubmed">29020853</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue JK, Kobeissy FH, Jain S, et al. . Neuroinflammatory biomarkers for traumatic brain injury diagnosis and prognosis: a TRACK-TBI Pilot Study. Neurotrauma Rep 2023;4(1):171&#x2013;183; doi: 10.1089/neur.2022.0060</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neur.2022.0060</ArticleId><ArticleId IdType="pmc">PMC10039275</ArticleId><ArticleId IdType="pubmed">36974122</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardner RC, Puccio AM, Korley FK, et al. . Effects of age and time since injury on traumatic brain injury blood biomarkers: a TRACK-TBI study. Brain Commun 2023;5(1):fcac316; doi: 10.1093/braincomms/fcac316</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcac316</ArticleId><ArticleId IdType="pmc">PMC9832515</ArticleId><ArticleId IdType="pubmed">36642999</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenovuo O, Diaz-Arrastia R, Goldstein LE, et al. . Assessing the severity of traumatic brain injury&#x2014;time for a change? J Clin Med 2021;10(1):148; doi: 10.3390/jcm10010148</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10010148</ArticleId><ArticleId IdType="pmc">PMC7795933</ArticleId><ArticleId IdType="pubmed">33406786</ArticleId></ArticleIdList></Reference><Reference><Citation>Joly BS, Darmon M, Dekimpe C, et al. . Imbalance of von Willebrand factor and ADAMTS13 axis is rather a biomarker of strong inflammation and endothelial damage than a cause of thrombotic process in critically ill COVID-19 patients. J Thromb Haemost 2021;19(9):2193&#x2013;2198; doi: 10.1111/jth.15445</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15445</ArticleId><ArticleId IdType="pmc">PMC8420340</ArticleId><ArticleId IdType="pubmed">34219357</ArticleId></ArticleIdList></Reference><Reference><Citation>Yatsiv I, Morganti-Kossmann MC, Perez D, et al. . Elevated intracranial IL-18 in humans and mice after traumatic brain injury and evidence of neuroprotective effects of IL-18-binding protein after experimental closed head injury. J Cereb Blood Flow Metab 2002;22(8):971&#x2013;978.</Citation><ArticleIdList><ArticleId IdType="pubmed">12172382</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne AM, Bouchier-Hayes DJ, Harmey JH. Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med 2005;9(4):777&#x2013;794; doi: 10.1111/j.1582-4934.2005.tb00379.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1582-4934.2005.tb00379.x</ArticleId><ArticleId IdType="pmc">PMC6740098</ArticleId><ArticleId IdType="pubmed">16364190</ArticleId></ArticleIdList></Reference><Reference><Citation>Kliche S, Waltenberger J. VEGF receptor signaling and endothelial function. IUBMB Life 2001;52(1&#x2013;2):61&#x2013;66; doi: 10.1080/15216540252774784</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15216540252774784</ArticleId><ArticleId IdType="pubmed">11795595</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu LB, Yue JK, Korley F, et al. . High-sensitivity C-reactive protein is a prognostic biomarker of six-month disability after traumatic brain injury: results from the TRACK-TBI Study. J Neurotrauma 2021;38(7):918&#x2013;927; doi: 10.1089/neu.2020.7177</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2020.7177</ArticleId><ArticleId IdType="pmc">PMC7987360</ArticleId><ArticleId IdType="pubmed">33161875</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer TF, Beck-Sickinger AG. Chemerin&#x2014;exploring a versatile adipokine. Biol Chem 2022;403(7):625&#x2013;642; doi: 10.1515/hsz-2021-0409</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/hsz-2021-0409</ArticleId><ArticleId IdType="pubmed">35040613</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong LR, Perlman S. Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses&#x2014;are we our own worst enemy? Nat Rev Immunol 2022;22(1):47&#x2013;56; doi: 10.1038/s41577-021-00656-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00656-2</ArticleId><ArticleId IdType="pmc">PMC8617551</ArticleId><ArticleId IdType="pubmed">34837062</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, Willscher E, Paschold L, et al. . The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep Med 2022;3(6):100663; doi: 10.1016/j.xcrm.2022.100663</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu NT, Salinas J. Machine learning for predicting outcomes in trauma. Shock 2017;48(5):504&#x2013;510; doi: 10.1097/shk.0000000000000898</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/shk.0000000000000898</ArticleId><ArticleId IdType="pubmed">28498299</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalili H, Rismani M, Nematollahi MA, et al. . Prognosis prediction in traumatic brain injury patients using machine learning algorithms. Sci Rep 2023;13(1):960; doi: 10.1038/s41598-023-28188-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-28188-w</ArticleId><ArticleId IdType="pmc">PMC9849475</ArticleId><ArticleId IdType="pubmed">36653412</ArticleId></ArticleIdList></Reference><Reference><Citation>Courville E, Kazim SF, Vellek J, et al. . Machine learning algorithms for predicting outcomes of traumatic brain injury: a systematic review and meta-analysis. Surg Neurol Int 2023;14:262; doi: 10.25259/sni_312_2023</Citation><ArticleIdList><ArticleId IdType="doi">10.25259/sni_312_2023</ArticleId><ArticleId IdType="pmc">PMC10408617</ArticleId><ArticleId IdType="pubmed">37560584</ArticleId></ArticleIdList></Reference><Reference><Citation>Dietz N, Vaitheesh J, Alkin V, et al. . Machine learning in clinical diagnosis, prognostication, and management of acute traumatic spinal cord injury (SCI): a systematic review. J Clin Orthop Trauma 2022;35:102046; doi: 10.1016/j.jcot.2022.102046</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcot.2022.102046</ArticleId><ArticleId IdType="pmc">PMC9678757</ArticleId><ArticleId IdType="pubmed">36425281</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald SJ, Shultz SR, Agoston DV. The known unknowns: an overview of the state of blood-based protein biomarkers of mild traumatic brain injury. J Neurotrauma 2021;38(19):2652&#x2013;2666; doi: 10.1089/neu.2021.0011</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2021.0011</ArticleId><ArticleId IdType="pubmed">33906422</ArticleId></ArticleIdList></Reference><Reference><Citation>Finnie J. Animal models of traumatic brain injury: a review. Aust Vet J 2001;79(9):628&#x2013;633.</Citation><ArticleIdList><ArticleId IdType="pubmed">11702936</ArticleId></ArticleIdList></Reference><Reference><Citation>Marklund N, Hillered L. Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here? Br J Pharmacol 2011;164(4):1207&#x2013;1229; doi: 10.1111/j.1476-5381.2010.01163.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1476-5381.2010.01163.x</ArticleId><ArticleId IdType="pmc">PMC3229758</ArticleId><ArticleId IdType="pubmed">21175576</ArticleId></ArticleIdList></Reference><Reference><Citation>Agoston DV, Kamnaksh A.. Modeling the Neurobehavioral Consequences of Blast-Induced Traumatic Brain Injury Spectrum Disorder and Identifying Related Biomarkers. In: Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. (Kobeissy FH. ed.) CRC Press/Taylor &amp; Francis: Boca Raton, FL; 2015.</Citation><ArticleIdList><ArticleId IdType="pubmed">26269904</ArticleId></ArticleIdList></Reference><Reference><Citation>Kochanek PM, Bramlett HM, Dixon CE, et al. . Approach to modeling, therapy evaluation, drug selection, and biomarker assessments for a multicenter pre-clinical drug screening consortium for acute therapies in severe traumatic brain injury: operation brain trauma therapy. J Neurotrauma 2016;33(6):513&#x2013;522; doi: 10.1089/neu.2015.4113</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2015.4113</ArticleId><ArticleId IdType="pubmed">26439468</ArticleId></ArticleIdList></Reference><Reference><Citation>Shultz SR, McDonald SJ, Vonder Haar C, et al. . The potential for animal models to provide insight into mild traumatic brain injury: translational challenges and strategies. Neurosci Biobehav Rev 2017;76(Pt B):396&#x2013;414; doi: 10.1016/j.neubiorev.2016.09.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2016.09.014</ArticleId><ArticleId IdType="pubmed">27659125</ArticleId></ArticleIdList></Reference><Reference><Citation>Brady RD, Casillas-Espinosa PM, Agoston DV, et al. . Modelling traumatic brain injury and posttraumatic epilepsy in rodents. Neurobiol Dis 2019;123:8&#x2013;19; doi: 10.1016/j.nbd.2018.08.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.08.007</ArticleId><ArticleId IdType="pmc">PMC6348144</ArticleId><ArticleId IdType="pubmed">30121231</ArticleId></ArticleIdList></Reference><Reference><Citation>Povlishock JT. Pathophysiology of neural injury: therapeutic opportunities and challenges. Clin Neurosurg 2000;46:113&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pubmed">10944671</ArticleId></ArticleIdList></Reference><Reference><Citation>Kochanek PM, Dixon CE, Mondello S, et al. . Multi-center pre-clinical consortia to enhance translation of therapies and biomarkers for traumatic brain injury: operation brain trauma therapy and beyond. Front Neurol 2018;9:640; doi: 10.3389/fneur.2018.00640</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00640</ArticleId><ArticleId IdType="pmc">PMC6090020</ArticleId><ArticleId IdType="pubmed">30131759</ArticleId></ArticleIdList></Reference><Reference><Citation>Kochanek PM, Bramlett HM, Shear DA, et al. . Synthesis of findings, current investigations, and future directions: operation brain trauma therapy. J Neurotrauma 2016;33(6):606&#x2013;614; doi: 10.1089/neu.2015.4133</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2015.4133</ArticleId><ArticleId IdType="pubmed">26671284</ArticleId></ArticleIdList></Reference><Reference><Citation>Jullienne A, Salehi A, Affeldt B, et al. . Male and female mice exhibit divergent responses of the cortical vasculature to traumatic brain injury. J Neurotrauma 2018;35(14):1646&#x2013;1658; doi: 10.1089/neu.2017.5547</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2017.5547</ArticleId><ArticleId IdType="pmc">PMC6016102</ArticleId><ArticleId IdType="pubmed">29648973</ArticleId></ArticleIdList></Reference><Reference><Citation>Valera EM, Joseph AC, Snedaker K, et al. . Understanding traumatic brain injury in females: a state-of-the-art summary and future directions. J Head Trauma Rehabil 2021;36(1):e1&#x2013;e17; doi: 10.1097/htr.0000000000000652</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/htr.0000000000000652</ArticleId><ArticleId IdType="pmc">PMC9070050</ArticleId><ArticleId IdType="pubmed">33369993</ArticleId></ArticleIdList></Reference><Reference><Citation>Prins ML, Hovda DA. Developing experimental models to address traumatic brain injury in children. J Neurotrauma 2003;20(2):123&#x2013;137; doi: 10.1089/08977150360547053</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/08977150360547053</ArticleId><ArticleId IdType="pubmed">12675967</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamm RJ, Jenkins LW, Lyeth BG, et al. . The effect of age on outcome following traumatic brain injury in rats. J Neurosurg 1991;75(6):916&#x2013;921; doi: 10.3171/jns.1991.75.6.0916</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/jns.1991.75.6.0916</ArticleId><ArticleId IdType="pubmed">1941121</ArticleId></ArticleIdList></Reference><Reference><Citation>Stocchetti N, Paterno R, Citerio G, et al. . Traumatic brain injury in an aging population. J Neurotrauma 2012;29(6):1119&#x2013;1125; doi: 10.1089/neu.2011.1995</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2011.1995</ArticleId><ArticleId IdType="pubmed">22220762</ArticleId></ArticleIdList></Reference><Reference><Citation>Roozenbeek B, Maas AI, Menon DK. Changing patterns in the epidemiology of traumatic brain injury. Nat Rev Neurol 2013;9(4):231&#x2013;236; doi: 10.1038/nrneurol.2013.22</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.22</ArticleId><ArticleId IdType="pubmed">23443846</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>